The German-based company expects to file its test for FFPE within the next few months, and to start a clinical trial for its cytology test by mid-year.
In return for access to Forma's compound library and cell-based screening platforms, Eisai will pay $20 million upfront and in committed funding over three years, plus potential milestone and royalty payments.
The firms have expanded an alliance to include cell culture media and high-performance toxicity assays for new cell-based tools for drug discovery and development.
A new NINDS and NIMH grant program will provide up to $5 million in grants to develop scalable assays for analysis of molecular and cellular events in neurons related to brain functioning.
Berlin-based Probiogen will provide its Human Artificial Lymph Node Technology to Affiris to search for vaccine candidates for potential clinical trials.
Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.
Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.
